Denali Therapeutics Inc. (DNLI) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Denali Therapeutics Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • Denali Therapeutics Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$1.22 B, a 12.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$1.22 B -$137 M -12.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1.12 B -$145 M -15% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$997 M -$124 M -14.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$897 M -$128 M -16.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$1.08 B -$371 M -52.2% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$971 M -$326 M -50.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$872 M -$303 M -53.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$769 M -$284 M -58.5% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$710 M -$286 M -67.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$645 M -$291 M -82% Dec 31, 2021 10-K 2023-02-27
Q3 2021 -$570 M +$29.6 M +4.93% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$485 M +$55.9 M +10.3% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 -$424 M +$57.9 M +12% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 -$354 M +$71.1 M +16.7% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$599 M -$228 M -61.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$541 M -$216 M -66.3% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 -$482 M -$215 M -80.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$426 M -$198 M -86.7% Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$372 M -$66.1 M -21.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$325 M -$55.2 M -20.4% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 -$267 M -$51.6 M -23.9% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$228 M -$36.2 M -18.9% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$305 M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$270 M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 -$215 M Mar 31, 2018 10-Q 2018-05-11
Q4 2017 -$192 M Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.